Literature DB >> 4053351

Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status.

B W Hollis, J L Napoli.   

Abstract

We describe a faster, more-sensitive radioimmunoassay for vitamin D in plasma. Antibodies were generated in rabbits immunized with a new vitamin D analog, the 23,24,25,26,27-pentanor-C(22)-carboxylic acid of vitamin D, coupled directly with bovine serum albumin. After several months, Rivanol-treated sera from the rabbits contained high-titer antibodies, as determined by their abilities to bind 25-hydroxy-[3H]cholecalciferol. The antibody, used at a 1:15 000 final dilution, cross reacted equally with all cholecalciferol and ergocalciferol metabolites tested except 1,25-dihydroxycalciferol metabolites and the parent calciferols. 25-Hydroxycalciferol and similar forms were efficiently extracted from plasma or serum with acetonitrile. We separated bound from free 25-hydroxy-[3H]cholecalciferol by using a second antibody: goat antiserum to rabbit serum. The detection limit of the assay was 3.0 pg of 25-hydroxycholecalciferol and its equivalents per tube; thus only 1 microL of plasma is needed per assay tube. Results compared well with those from a liquid-chromatographic procedure involving specific ultraviolet detection of 25-hydroxycalciferol in plasma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4053351

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  20 in total

1.  Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study.

Authors:  John M Brehm; Brooke Schuemann; Anne L Fuhlbrigge; Bruce W Hollis; Robert C Strunk; Robert S Zeiger; Scott T Weiss; Augusto A Litonjua
Journal:  J Allergy Clin Immunol       Date:  2010-06-09       Impact factor: 10.793

2.  Model-based meta-analysis for development of a population-pharmacokinetic (PPK) model for Vitamin D3 and its 25OHD3 metabolite using both individual and arm-level data.

Authors:  Alanna S Ocampo-Pelland; Marc R Gastonguay; Jonathan F French; Matthew M Riggs
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-02-12       Impact factor: 2.745

3.  Improving the measurement of 25-hydroxyvitamin D.

Authors:  Andrew M Wootton
Journal:  Clin Biochem Rev       Date:  2005-02

4.  The assessment of circulating 25(OH)D and 1,25(OH)2D: where we are and where we are going.

Authors:  Bruce W Hollis; Ronald L Horst
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-02       Impact factor: 4.292

5.  Determinants and Measurement of Neonatal Vitamin D: Overestimation of 25(OH)D in Cord Blood Using CLIA Assay Technology.

Authors:  Mengdi Lu; Bruce W Hollis; Vincent J Carey; Nancy Laranjo; Ravinder J Singh; Scott T Weiss; Augusto A Litonjua
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

6.  Cord blood vitamin D status impacts innate immune responses.

Authors:  Valencia P Walker; Xiaoran Zhang; Ida Rastegar; Philip T Liu; Bruce W Hollis; John S Adams; Robert L Modlin
Journal:  J Clin Endocrinol Metab       Date:  2011-04-06       Impact factor: 5.958

7.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.

Authors:  Joann E Manson; Shari S Bassuk; I-Min Lee; Nancy R Cook; Michelle A Albert; David Gordon; Elaine Zaharris; Jean G Macfadyen; Eleanor Danielson; Jennifer Lin; Shumin M Zhang; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

8.  Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users.

Authors:  Michelle M Estrella; Gregory D Kirk; Shruti H Mehta; Todd T Brown; Derek M Fine; Mohamed G Atta; Gregory M Lucas
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

9.  Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica.

Authors:  John M Brehm; Juan C Celedón; Manuel E Soto-Quiros; Lydiana Avila; Gary M Hunninghake; Erick Forno; Daniel Laskey; Jody S Sylvia; Bruce W Hollis; Scott T Weiss; Augusto A Litonjua
Journal:  Am J Respir Crit Care Med       Date:  2009-01-29       Impact factor: 21.405

10.  Bone histology in steroid-treated children with non-azotemic nephrotic syndrome.

Authors:  Michael Freundlich; Michael Jofe; William G Goodman; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2004-02-26       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.